HIGHLIGHTS
- who: from the Editorial Comment: Secondary polycythemia in men receiving testosterone therapy increases risk of major adverse cardiovascular events and venous thromboembolism in the first year of therapy Jesse Ory, Sirpi Nackeeran, Navin CBalaji, Joshua M. Hare, Ranjith Ramasamy , University of Miami, Department of Urology, Miami, Florida have published the research: UPDATE IN UROLOGY, in the Journal: (JOURNAL)
- future: Despite these findings further studies are needed to confirm the association between TT dosage and patient adherence to secondary polycythemia and MACE/VTE.
SUMMARY
Jun;207(6):1295-1301. _____________________________________________ DOI: 10 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.